Mar 3, 2026 07:00AM
Dec 19, 2025 09:06AM
Dec 5, 2025 09:00AM
Dec 5, 2025 09:00AM
Nov 6, 2025 07:00AM
Oct 20, 2025 07:49AM
Oct 8, 2025 08:44AM Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and Vestis Corp. (NYSE: VSTS): Grabar Law Office
Aug 27, 2025 07:05AM
Aug 27, 2025 07:00AM
Aug 7, 2025 07:00AM
Jul 14, 2025 03:41PM
Jul 13, 2025 05:00PM
Jul 8, 2025 07:00AM
Jun 17, 2025 05:17AM Citi Starts Amylyx Pharmaceuticals inc. (AMLX) at Buy
Jun 3, 2025 07:01AM
Jun 3, 2025 07:00AM
May 12, 2025 07:01AM
May 12, 2025 07:00AM
May 8, 2025 07:00AM
Apr 30, 2025 07:03AM
Apr 30, 2025 07:00AM Amylyx Pharmaceuticals Announces First Participant Dosed in Pivotal Phase 3 LUCIDITY Trial of Avexitide in Post-Bariatric Hypoglycemia
Mar 4, 2025 06:00AM
Jan 21, 2025 09:00AM
Jan 21, 2025 09:00AM
Jan 6, 2025 09:00AM
Dec 4, 2024 07:32AM
Dec 4, 2024 07:30AM
Nov 21, 2024 05:09AM Goldman Sachs Reiterates Neutral Rating on Amylyx Pharmaceuticals inc. (AMLX)
Nov 7, 2024 07:00AM
Oct 18, 2024 06:44AM
Oct 18, 2024 05:46AM
Oct 17, 2024 09:01AM
Oct 17, 2024 09:00AM
Aug 8, 2024 07:00AM
Aug 2, 2024 09:00AM Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for AMX0035 for the Treatment of Wolfram Syndrome
Jul 11, 2024 10:30AM
Jul 10, 2024 07:00AM
Jul 10, 2024 07:00AM
May 9, 2024 07:00AM
Apr 10, 2024 09:02AM
Apr 10, 2024 09:00AM
Apr 4, 2024 07:02AM Amylyx Pharmaceuticals (AMLX) to Remove RELYVRIO/ALBRIOZA from the Market; Provides Updates on Access to Therapy, Pipeline, Corporate Restructuring, and Strategy
Apr 4, 2024 07:00AM
Apr 1, 2024 11:30AM
Mar 29, 2024 09:00PM
Mar 25, 2024 09:00PM
Mar 25, 2024 12:30PM
Mar 21, 2024 09:00PM
Mar 18, 2024 12:30PM AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Amylyx
Mar 17, 2024 09:00PM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All